Cytokinetics | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Amgen USD 23.01B 91M 2025-03
Bayer EUR 27.96B 993M 2025-03
Biogen USD 5.3B 231.4M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Cytokinetics USD 159.73M 19.95M 2025-03
Eisai JPY 372.29B 9.32B 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Exelixis USD 399.1M 4.67M 2025-04
Geron USD 63.03M 25.26M 2025-03
Halozyme Therapeutics USD 150.38M 11.28M 2025-03
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Ligand Pharmaceuticals USD 58.68M 21.57M 2025-03
Merck USD 25.17B 3.25B 2025-03
Novartis USD 28.69B 560M 2024-12
Pfizer USD 36.45B 6.54B 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 32.22B 3.06B 2025-03



Cytokinetics Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.